The Journal of Neuroscience, July 2, 2003, 23(13):5693-5697
Previous Article | Next Article 
BRIEF COMMUNICATION
D3 Dopamine Autoreceptors Do Not Activate G-Protein-Gated Inwardly Rectifying Potassium Channel Currents in Substantia Nigra Dopamine Neurons
Viviana Davila,1
Zhen Yan,4
Liviu C. Craciun,5
Diomedes Logothetis,5 and
David Sulzer1,2,3
Departments of 1Neurology and
2Psychiatry, Columbia University, and
3Department of Neuroscience, New York Psychiatric
Institute, New York, New York 10032,4Department of
Physiology and Biophysics, State University of New York at Buffalo, Buffalo,
New York 14214, and 5Department of Physiology and
Biophysics, Mt. Sinai School of Medicine, New York, New York 10029
 |
Abstract
|
|---|
Substantia nigra (SN) dopamine neurons express D2 and
D3 dopamine autoreceptors. A physiological role for the
D3 receptor has not been identified, but an activation of
G-protein-gated inwardly rectifying potassium (GIRK; also known as Kir3)
channels is strongly implicated because D3 receptors activate
channels composed of GIRK2 subunits in cell lines. We confirmed that acutely
dissociated SN dopamine neurons indeed contain D3 and GIRK2 subunit
mRNA using single-cell RT-PCR. We then tested whether D3 receptors
activate GIRK currents in SN dopamine neurons by comparing acutely dissociated
neurons from D2/ receptor knock-out and congenic
wild-type mice. In nearly all (14 of 15) wild-type SN dopamine neurons, the
D2/D3 agonist quinpirole activated GIRK currents that
were blocked by cesium. Quinpirole, however, elicited no GIRK currents in any
SN dopamine neuron (0 of 13) derived from D2/
receptor knock-out mice. The absence of quinpirole response was not caused by
a lack of GIRK activity, because the GABAB receptor agonist
baclofen continued to elicit these currents in the mutant neurons. Thus, it
appears that D3 activation of GIRK currents in SN neurons does not
occur or is exceedingly rare.
Key words: GABA; inwardly rectifying potassium channel; Kir3; single-cell RT-PCR; weaver mouse mutation; ventral tegmental area
 |
Introduction
|
|---|
Although various autoreceptor-mediated responses in substantia nigra (SN)
dopamine neurons are mediated by D2 receptors
(Usiello et al., 2000
), the
physiological roles, distribution, and even existence of D3
autoreceptors in the SN have been intensely debated. A recent study, however,
reports D3 immunoreactivity in all midbrain dopamine neurons
(Diaz et al., 2000
). Various
pharmacological studies using ligands with a preferential binding affinity for
D3 receptors (Lejeune and
Millan, 1995
; Aretha and
Galloway, 1996
; Gainetdinov et
al., 1996
) or oligonucleotides that inhibit D3
transcription (Tepper et al.,
1997
) suggest possible physiological roles for D3
autoreceptors. Yet, SN neurons from D3/ mice display
normal basal firing rates, rates of dopamine synthesis, basal dopamine levels,
and reuptake kinetics (Koeltzow et al.,
1998
; L'Hirondel et al.,
1998
; Dickinson et al.,
1999
; Zapata et al.,
2001
). In summary, there is as yet no clear evidence of a
physiological role for D3 autoreceptors.
A strong candidate for such a role is suggested by studies in transfected
cell lines expressing D3 receptors and GIRK2, a subunit of the
G-protein coupled inwardly rectifying potassium channels (GIRKs; also known as
Kir3) that is selectively expressed in SN neurons
(Inanobe et al., 1999
;
Liss et al., 1999
). Cells
cotransfected with D3 receptors and GIRK2 exhibit GIRK activation
by the D2/D3 receptor agonist quinpirole
(Kuzhikandathil et al., 1998
;
Kuzhikandathil and Oxford,
2000
). A D3 autoreceptor activation of GIRK currents,
however, has yet to be tested directly in neurons. Here, we used SN neurons
derived from D2 null mutant (/) mice, which express
ventral midbrain D3 receptor at higher levels than wild-type
littermates (Jung et al.,
1999
), to determine whether D3 autoreceptors activate
GIRK currents.
 |
Materials and Methods
|
|---|
Preparation of acutely dissociated neurons. Experiments were
performed in accordance with the Columbia University Institutional Animal Care
and Use Committee. Except where noted, reagents were obtained from Sigma (St.
Louis, MO). Neurons were derived from C57BL6 mice (Taconic, Germantown, NY),
or, in the case of D2 receptor / knock-out mutants,
their wild-type siblings and wild-type non-siblings from the same mixed 129
Sr/C57BL6 background (Jung et al.,
1999
). Mice were anesthetized on postnatal day 1829 using
ketamine/xylazine (5 mg/ml and 3.4 mg/ml, respectively) by intraperitoneal
injection, (0.1 ml/30 gm). The SN was dissected from 300 µm vibratome
slices and dissociated at 34°C in continuously oxygenated solution with
1.34 mg/ml protease (type XIV; Sigma) in HBSS (containing in mM):
10 HEPES, 2 MgCl2, 1 CaCl2, pH 7.34), for 30 min,
and cells were plated on poly-D-lysinecoated (40 mg/ml in
dH2O) coverslips. Cultures were superfused with oxygenated
physiological saline (in mM): 150 NaCl, 2 KCl, 1 MgCl2,
1.2 CaCl2, 10 HEPES, and 25 glucose, pH 7.37.4, throughout
the recordings, and recordings were completed within 6 hr after
dissociation.
cDNA synthesis. Cytosol was harvested by aspiration into a patch
pipette filled with 5 µl of DEPC-treated water followed by expiration into
5.3 µl of DEPC-treated water, 7.1 mM DTT, 7 U RNAsin, 0.5 µg
of oligo-dT, maintained in dry ice. Five microliters of the saline surrounding
the cells were collected to provide negative controls. The cytosol/primer or
saline/primer mixtures (12 µl of each) were incubated for 10 min at
70°C and placed on ice. To the cytosol/oligo-dT primer mixtures, 8 µl
of reverse transcriptase reaction mix (1x PCR buffer, 2.5 mM
MgCl2, 0.5 mM dNTP mix, 7.5 mM DTT, 7 U
RNasin, 10 U Superscript II RT, and DEPC H2O) was added. The RT
reaction mixture was incubated for 50 min at 42°C, followed by 15 min at
70°C, and then chilled on ice. To remove RNA, 2 U of RNaseH was added to
each tube, incubated for 20 min at 37°C, and stored at
80°C.
Trizol reagent (Invitrogen) used for whole-tissue RNA extraction was used
according to the manufacturer's instructions. To produce cDNA from RNA
isolated from mouse striatum, 10 µl of RNA isolate was mixed with 0.5 µg
of oligo-dT and heated to 65°C for 10 min. The RNA/oligo-dT reaction was
then used for PCR amplification. The PCR reaction mix contained 1x PCR
buffer, 2.5 mM MgCl2, 0.5 mM dNTP mix, 7.5
mM DTT, 14 U RNasin, and 10 U Superscript II RT. The RT-PCR
reaction was performed with the following heating cycle: 42°C for 50 min,
70°C for 15 min, 4°C for 1 min. RNaseH (3.4 U) was added to the
reaction and incubated for 20 min at 37°C followed by 1 min at 4°C.
Mouse striatal cDNA was stored at 70°C and used in all PCR
reactions as a control because tyrosine hydroxylase (TH), D2,
D3, and GIRK14 are each expressed in this tissue.
PCR amplification. Reagents for PCR amplification of DNA were
obtained from Promega (Madison, WI).
The analysis of single neurons used the following TH primer sequence: TH
sense: 5'-CAGGACATTGGACTTGCATCTCTG; TH antisense:
5'-ATAGTTCCTGAGCTTGTCCTTGGC (296 bp).
The PCR reaction mixture for amplification of the TH transcript contained
1x PCR buffer, 2.5 mM MgCl2, 0.5 mM
dNTP, 0.8 µM sense primer, 0.8 µM antisense
primer, 2 µl of single-cell cDNA (or 1 µl (0.58 µg) of striatal
cDNA), and 0.5 µlof Taq in 50 µl. Amplification of TH was
performed as follows: (1) 4 min at 94°C, (2) 45 cycles of 1 min at
94°C, 1 min at 56°C, and 1.5 min at 72°C, and (3) 5 min at
72°C, held at 4°C.
To determine whether mice expressed the D2 mutation, we used a
primer sequence designed to amplify exon 1 of D2, which is deleted
in this mutant: mD2 sense: 5'-CAATGGATCCACTGAAC;
mD2 antisense: 5'-ACCACCTCCAGATAGAC (290 bp).
The PCR reaction mixture for amplification of this transcript contained
1x PCR buffer, 2.5 mM MgCl2, 0.5 mM
dNTP, 40 pM of sense primer, 40 pM of antisense primer,
3 µl of single-cell cDNA (or 1 µl (0.58 µg) of striatal cDNA), 0.2
µl of Taq in 20 µl. Amplification of the D2-exon1
transcript was performed as follows: (1) 4 min at 94°C, (2) 35 cycles of 1
min at 94°C, 1 min at 52°C, and 1.3 min at 72°C, (3) 5 min at
72°C, and held at 4°C.
The following nested primer sequences for D2
(Yan et al., 1997
),
D3, and GIRK subunits Girk14 were used for those neurons
that were identified as dopaminergic: D2-external sense:
5'-GCAGTCGAGCTTTCAGAGCC; D2-external antisense:
5'-TCTGCGGCTCATCGTCTTAAG (404/317bp); D2-internal sense:
5'-AGAGCCAACCTGAAGACACCAC; D2-internal antisense:
5'-CTTAAGGGAGGTCCGGGTTTTG (375/288 bp); D3-external sense:
5'-GATCCCAGCATCTGCTCCATCTC; D3-external antisense:
5'-ATCTTGAGGAAGGCTTTGCGGAA (757/694 bp); D3-internal sense:
5'-CCATCTCCAACCCTGATTTTGTC; D3-internal antisense:
5'-TCTAAGCTGAGCTTGGGTGCCAT (483/420 bp); mGirk1,3,4 external sense:
5'-TTCACYACSCTGGTGGAYCT; mGirk1,3,4 external antisense:
5'-GCTTGRCAMGTCATWCCYGT; mGirk1 internal sense:
5'-AACAAAGCCCATGTCGGCAACTAC; mGirk1 internal antisense
CTGTTCAGTTTGCATGCTTCGCTG (539 bp); mGirk3 internal sense:
5'-CTCAGACTGCTCTTCTTCGTGCTC; mGirk3 internal antisense:
5'-GTCGGTCTGGTGCAAAGGGATGAA (506 bp); mGirk4 internal sense:
5'-TCACCATGGTCTACACCATCACCT; mGirk4 internal antisense:
5'-CTCGTTGATCTCGTGGGAGATGAT (568 bp); mGirk2 external sense:
5'-TTCACCACCCTGGTGGACCT; Girk2 external antisense:
5'-GCTTGGCACGTCATTCCTGT; mGirk2 internal sense:
5'-TGTCATGGTCTACACAGTGACGTG; mGirk2 internal antisense:
5'-TTCCTCTTTAGGCAGCTGCGCTTT (615 bp).
Amplification of wild-type D2, D3, and the four GIRK
subunits, Girk14, was performed with two rounds of cycling. The PCR
reaction mixture for the first round of amplification of transcripts using
nested primer sequences contained 1x PCR buffer, 3 mM
MgCl2, 0.5 mM dNTP, 0.3 µM each of
external sense and antisense primer, 2.5 µl of single-cell cDNA, (or 1
µl (0.58 µg) of striatal cDNA), and 0.2 µl of Taq in 20
µl. First round was as follows: (1) 4 min at 94°C, (2) 35 cycles of 1
min at 94°C, 1 min at 50°C, and 1.5 min at 72°C, (3) 5 min at
72°C, and then (4) held at 4°C.
The PCR reaction mixtures for the second round of amplification of
wild-type D2, D3, and mGirk14 contained 1x
PCR buffer, 2.5 mM MgCl2, 0.5 mM dNTP, 0.6
µM each of internal sense and antisense primer, 0.5 µl of
first-reaction product, 0.2 µl of Taq and DEPC-treated water in 20
µl. Second round was as follows: (1) 4 min at 94°C, (2) 45 cycles of 1
min at 94°C, 1 min at 56°C, and 1.5 min at 72°C, (3) 5 min at
72°C, and then held at 4°C.
Electrophysiology. The patch pipette resistance was 615
M
and access resistances were <10 M
. Current traces were
acquired using an Instrunet board and Axopatch 200 B amplifier and sampled at
20 kHz. The average whole-cell capacitance was 7.5 ± 0.6 pF (range:
3.910.3 pF). Input resistances for the three genotypes were not
significantly different [C57BL6, 0.9 ± 0.11 G
(mean ±
SEM); D2/ knock-outs, 0.9 ± 0.02 G
; mixed
129/C57l6, 1.2 ± 0.37 G
]. Cells were recorded for no more than
11 min, and normal leak currents and input resistances were maintained during
that period. Cells with leak currents >82 pA were not included in the
analysis.
The internal recording solution contained (in mM): 55
K2SO4, 30 KF/2H2O, 60 sucrose, 5 HEPES, 5
BAPTA (K4 salt), 3 MgCl2, 2.8 CaCl2, 3.8
Mg-ATP, 0.2 Na2-GTP, 3.1 mg/ml phospocreatine, pH 7.36,
296
mOsm. The external control recording solution contained (in mM): 20
potassium gluconate, 5 HEPES, 10 glucose, 140 N-methylgluconate, 2
MgCl2, 0.5 CaCl2, pH 7.41, with 156 mM HCl
and 10 mM KOH, 313 mOsm. The liquid junction potential between the
external and internal solution was
1.7 mV.
Quinpirole or baclofen (Research Biochemicals, Natick, MA) was applied by
local perfusion concurrently with a series of voltage changes controlled by
locally written software (V. Davila) in Igor. In brief, (1) a trigger
stimulated perfusion of control solution (external solution, no drug) while
voltage was held at 50 mV for 1 sec; (2) a trigger stimulated perfusion
of the experimental solution (external solution plus drug) while the neuronal
voltage was held at 50 mV for 1 sec; (3) perfusion of the same
experimental solution was maintained during a voltage ramp from 20 to
120 mV within 1.3 sec; and 4) a trigger stimulated perfusion of control
solution while the voltage was held at 50 mV, 1 sec. At the end of the
protocol, the voltage remained at 50 mV. Traces were 25x box
smoothed, and the corresponding cesium current was subtracted from control and
experimental currents from the same cell. Signal slopes were derived from a
best-fit line of the cesium-subtracted inward rectifying current corresponding
to the voltage ramp between 70 and 110 mV.
Immunocytochemistry. Postnatally derived ventral midbrain cultures
were processed for TH peroxidase immunocytochemistry as published
(Burke et al., 1998
). For
fluorescent immunolabel, cultures were fixed in methanol at 20°C
for 15 min and exposed to rabbit primary anti-GIRK2 polyclonal antibodies
(APC006; Alomone Labs, Jerusalem, Israel) at a dilution of 1:400 and
monoclonal anti-TH antibody (Boehringer Mannheim, Mannheim, Germany) at a
dilution of 1:1000, in 10% normal goat serum in PBS + 1:1000 dilution of
Tween-20 at 4°C for 12 hr. After washing, the cultures were incubated with
secondary fluorescent antibodies [Alexa Fluor 568goat anti-rabbit IgG
and Alexa Fluor 488goat anti-mouse IgG (Molecular Probes, Eugene, OR)],
each at a dilution of 1:1000, for 1 hr at room temperature.
 |
Results
|
|---|
Kir3 channel activation
We adapted procedures used previously to characterize striatal neurons
(Surmeier et al., 1998
) to
obtain acutely dissociated SN neurons from prepared midbrain slices. We chose
this preparation because it is possible to quickly exchange media and drugs to
test multiple responses by a given neuron and because mRNA detection may be
more accurate in comparison with more intact systems. Most acutely dissociated
neurons retained portions of their proximal dendrites
(Fig. 1a), so our
recordings reflect currents in the cell body and proximal dendrites with no
components from axons or distal dendrites. The dopaminergic identity of the
neurons was confirmed by TH immunolabel
(Fig. 1b).

View larger version (44K):
[in this window]
[in a new window]
|
Figure 1. a, b, An example of an acutely dissociated SN neuron before
whole-cell patch-clamp recording and cytosol extraction (a). The same
neuron is shown after recording and DAB immunolabeling for TH (b).
Scale bar, 10 µm. c, Electrophoretic separation of amplified
RT-PCR products. In striatal tissue, used as a positive control, amplified
products are present for TH, D2 (long and short isoforms),
D3, and all GIRK14 subunits. Thus, all of the transcripts of
interest can be detected with the primers used. The leftmost lane indicates
standards with numbers of base pairs as indicated. d, Coexpression
profiles of mRNA for GIRK subunits and dopamine autoreceptors in single
TH-expressing SN neurons (n = 19). The horizontal bars indicate the
fraction of neurons that express a specific mRNA, which is also reported as a
percentage of total neurons at right. In this manner of display, the extent of
coexpression of the various mRNAs can be determined by examining the vertical
overlap of the bars. eg, Immunofluorescence label for
GIRK2 and TH. Examples from an SN neuronal culture immunolabeled for anti-TH
(e), anti-GIRK2 (f), and colocalization of the antigens
(g) (in yellow) are shown. The arrow indicates an example of a
nondopaminergic neuron that expresses GIRK2. Scale bar, 5 µm.
|
|
To confirm the presence of GIRK subunits, cytosol from individual neurons
was screened by RT-PCR amplification for GIRK subunit mRNA. Parallel PCR
amplification reactions were run using cDNA produced from mouse striatal
tissue to control for proper amplification of desired gene products with our
primers (Fig. 1c). We
chose to use striatal tissue because all of the genes in question, including
TH, are present in this region, whereas GIRK4 may not be present in substantia
nigra compacta (Murer et al.,
1997
). Individual neurons were first identified as dopaminergic by
PCR amplification with primers for TH and selected for further amplification
with primers that specifically amplify mRNA for D2, D3,
and the mammalian GIRK subunits (GIRK14). D2 mRNA was
expressed in 84% and D3 in 21% of TH-expressing SN neurons
(n = 19) (Fig.
1d). Each neuron that expressed D3 mRNA also
expressed D2 mRNA. Of the 16 neurons that coexpressed D2
and TH, 11 neurons expressed GIRK2, confirming the abundance of this subunit
in SN dopamine neurons.
GIRK mRNA expression levels are likely underestimated because only a
fraction of the total cDNA was used for PCR amplification and possibly because
of cellular damage that occurred during the preparation. We thus used
immunolabel for TH and GIRK2 to label SN neurons after 910 d in
vitro using our previously established culture methods for postnatally
derived SN neurons (Burke et al.,
1998
). GIRK2 protein was excluded from the nucleus but was
otherwise located throughout the cell, including the soma, dendrites, and axon
(Fig.
1eg). GIRK2 immunoreactivity was present
in 89% of TH-expressing neurons in the SN and in 33% of TH-negative SN neurons
(460 neurons rated). Thus, GIRK2 is preferentially expressed in dopaminergic
neurons (p < 0.0001; Fisher's exact test). Unfortunately, the
commercially available GIRK1 antibodies that we examined nonspecifically
labeled both control and GIRK1-transfected cell lines (data not shown).
In SN dopamine neurons derived from wild-type animals, voltage-ramp
recordings in the presence of TTX induced a small inwardly rectifying current
at voltages below the expected Nernst potential for potassium. Application of
the D2/D3 agonist quinpirole (1 µM)
activated an inwardly rectifying current
300% greater than the
agonist-independent current (n = 8)
(Fig. 2a,
Table 1). Both the
agonistindependent and quinpirole-induced inwardly rectifying currents were
abolished with the potassium channel blockers cesium (1 mM) or
barium (100 µM) (Table
1). Additional neurons were exposed to quinpirole during applied
voltage steps and then examined with TH/DAB immunolabel. Fourteen of 15
TH-expressing wild-type neurons (11 derived from C57BL6 mice and 4 derived
from wild-type mice from the same mixed 129Sr/C57BL6 genomic background as the
D2/ mutants) displayed inwardly rectifying currents
in response to quinpirole.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 2. a, A voltage ramp (20 to 120 mV) elicited an
endogenous small inwardly rectifying current in a wild-type dopaminergic SN
neuron (control). A prominent rectifying current was elicited in the presence
of 1µM quinpirole. After removal of quinpirole, there was a
recovery to nearly initial levels. The thin black lines superimposed on the
current traces indicate the slopes, between 70 and 110 mV,
reported in Table 1.
b, In a dopaminergic SN neuron derived from a
D2/ mutant, little endogenous inwardly rectifying
current was observed (control), and quinpirole did not activate any inwardly
rectifying current. A second control voltage ramp after quinpirole again
elicited no inwardly rectifying current (recovery); however, a subsequent
application of 50 µM baclofen elicited an inwardly rectifying
current.
|
|
To test whether expression of D3 autoreceptors was sufficient
for the quinpirole-activated inwardly rectifying current, we examined SN
dopamine neurons derived from D2/ mice. Quinpirole
did not potentiate the endogenous voltage-dependent inward rectifying current
in any mutant neuron (n = 13)
(Fig. 2b,
Table 1). The fractions of
either TH-positive wild-type or TH-positive D2/
neurons that responded to quinpirole (14 of 15 and 0 of 13, respectively)
strongly suggest that the expression of D2 receptors is required
for quinpirole activation of SN GIRK currents (p < 0.0001;
Fisher's exact test).
The absence of quinpirole activation of GIRK current in
D2/ neurons could be caused by either a lack of
D2 receptors or an absence of functional GIRK channels in the
mutant SN neurons. To test whether GIRK currents were still functional in
D2/ SN dopamine neurons, we applied the
GABAB receptor agonist baclofen (50 µM), which
activates GIRK channels in SN neurons
(Slesinger et al., 1997
;
Uezono et al., 1998
). For
those D2/ SN dopamine neurons exposed to quinpirole
and baclofen in succession, baclofen induced an inwardly rectifying current in
7 of 11 neurons, whereas quinpirole produced an inwardly rectifying current in
none (Fig. 2b,
Table 1). We conclude that
functional GIRK channels were present in SN dopaminergic neurons of
D2/ mutant mice.
 |
Discussion
|
|---|
Although a physiological response to D3 dopamine autoreceptor
activation has not been identified in neurons, D3 receptors
activate GIRK currents in cell lines that coexpress D3 and GIRK2,
(Kuzhikandathil et al., 1998
;
Kuzhikandathil and Oxford,
2000
). To test a similar function for neuronal D3
autoreceptors directly, we elicited GIRK currents in acutely dissociated SN
dopamine neurons derived from wild-type and D2/ mice
with quinpirole, a D2/D3 agonist. The quinpirole-induced
currents were identified as GIRK channels because (1) they were abolished by
the potassium channel blockers cesium and barium, (2) they displayed inward
current below the activation range of most other potassium channels, (3) the
voltage-ramp protocol used inactivates voltage-gated K channels before the
onset of inwardly rectifying currents, and (4) the absence of sodium in the
internal and external solutions, as well as the presence of tetrodotoxin,
prevented activation of Ih currents.
We used acutely dissociated neurons from 3-week-old mice because this is
the period of highest D3 autoreceptor expression in wild-type mice,
as well as a period of higher D3 expression in
D2/ than in wild-type mice
(Jung et al., 1999
). We
observed GIRK current responses to quinpirole application in 14 of 15
wild-type SN dopamine neurons recorded, but in none of 13 SN dopamine neurons
derived from D2/ mice. Because quinpirole is an
agonist for both D2 and D3 receptors, this striking
difference argues against coupling of D3 autoreceptors and GIRK
currents in SN neurons. Because of the fractions of neurons with detectable
D3 autoreceptors and GIRK subunit mRNAs (21 and 74%, respectively)
and the small sample size of D2/ SN DA neurons that
we recorded (n = 13), we may have missed a subpopulation of SN DA
neurons in which D3 activation elicits GIRK currents. If there is
D3 activation of GIRK currents in SN neurons, however, it must be
exceedingly rare in comparison with SN neurons that exhibit D2
activation of these currents.
A possible criticism of our approach is that the function of GIRK2 or
D3 could be disrupted in acutely dissociated neurons. We tested
this possibility in various control experiments. First, we showed that the
lack of a response to quinpirole in D2/ mice was not
caused by a loss of GIRK channel expression, because GIRK-mediated currents
were elicited in D2/ SN dopamine neurons by a
GABAB receptor agonist. Second, although we cannot prove directly
that these GIRK currents are mediated by GIRK2 subunits by the voltage-clamp
recordings, we confirmed high GIRK2 subunit expression in SN dopamine neurons,
as shown in vivo (Inanobe et al.,
1999
; Liss et al.,
1999
). Third, although we do not have a means to prove that
D3 autoreceptor is functional, we showed that its message is
present under conditions in which the D2 autoreceptor is
functional.
It should be noted that the fraction of neurons that express GIRK2 subunits
and D3 autoreceptor as detected by single-cell RT-PCR is likely
underestimated, because the GIRK subunit mRNA within the fraction of extracted
cytosol may not be abundant enough to be detected in every neuron, and
degradation may occur during cell harvesting. Although 26% of wild-type
TH-expressing SN neurons (5 of 19) were devoid of GIRK subunit mRNA, 14 of 15
(93%) of wild-type dopamine SN neurons that we recorded exhibited
quinpirole-induced GIRK currents. Similarly, although only 21% of acutely
dissociated neurons displayed detectable D3 mRNA,
immunocytochemical results indicate that all SN dopamine neurons express
D3 autoreceptor protein (Diaz et
al., 2000
); however, the physiological function of the
D3 autoreceptor remains to be elucidated.
 |
Footnotes
|
|---|
Received Feb. 12, 2003;
revised Apr. 16, 2003;
accepted Apr. 16, 2003.
This work was supported by National Science Foundation, National Institute
of Mental Health (Z.Y.), National Heart, Lung, and Blood Institute (D.L.),
National Institute on Drug Abuse, National Institute of Neurological Disorders
and Stroke, National Alliance for Research on Schizophrenia on Depression,
Parkinson's Disease Foundation, and Lowenstein Foundation (D.S.). We are
grateful to Drs. James Surmeier and Yvonne Schmitz for critiques and comments
and to Dr. Claudia Schmauss for providing mutant mice and comments.
Correspondence should be addressed to David Sulzer, 650 West 168th Street,
New York, NY 10032. E-mail:
ds43{at}columbia.edu.
V. Davila's current address: The Vollum Institute, Oregon Health and
Science University, 3181 Sam Jackson Park Road, Portland OR 97201-3098.
Copyright © 2003 Society for Neuroscience
0270-6474/03/235693-05$15.00/0
 |
References
|
|---|
Aretha CW, Galloway MP (1996) Dopamine autoreceptor
reserve in vitro: possible role of dopamine D3 receptors. Eur J
Pharmacol 305:
119122.[Medline]
Burke RE, Antonelli M, Sulzer D (1998) Glial cell
line-derived neurotrophic growth factor inhibits apoptotic death of postnatal
substantia nigra dopamine neurons in primary culture. J
Neurochem 71:
517525.[Web of Science][Medline]
Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC,
Sokoloff P (2000) Dopamine D3 receptors expressed by all
mesencephalic dopamine neurons. J Neurosci
20:
86778684.[Abstract/Free Full Text]
Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly
MA, Grandy DK, Low MJ, Gerhardt GA, Zahniser NR (1999) Dopamine
D2 receptor-deficient mice exhibit decreased dopamine transporter function but
no changes in dopamine release in dorsal striatum. J Neurochem
72: 148156.[Web of Science][Medline]
Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS
(1996) In vivo evidence for preferential role of dopamine D3
receptor in the presynaptic regulation of dopamine release but not synthesis.
Eur J Pharmacol 308:
261269.[Web of Science][Medline]
Inanobe A, Yoshimoto Y, Horio Y, Morishige KI, Hibino H, Matsumoto
S, Tokunaga Y, Maeda T, Hata Y, Takai Y, Kurachi Y (1999)
Characterization of G-protein-gated K+ channels composed of Kir3.2 subunits in
dopaminergic neurons of the substantia nigra. J Neurosci
19:
10061017.[Abstract/Free Full Text]
Jung MY, Skryabin BV, Arai M, Abbondanzo S, Fu D, Brosius J,
Robakis NK, Polites HG, Pintar JE, Schmauss C (1999) Potentiation
of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors.
Neuroscience 91:
911924.[Web of Science][Medline]
Koeltzow TE, Xu M, Cooper DC, Hu XT, Tonegawa S, Wolf ME, White FJ
(1998) Alterations in dopamine release but not dopamine
autoreceptor function in dopamine D3 receptor mutant mice. J
Neurosci 18:
22312238.[Abstract/Free Full Text]
Kuzhikandathil EV, Oxford GS (2000) Dominant-negative
mutants identify a role for GIRK channels in D3 dopamine receptor-mediated
regulation of spontaneous secretory activity. J Gen Physiol
115:
697706.[Abstract/Free Full Text]
Kuzhikandathil EV, Yu W, Oxford GS (1998) Human
dopamine D3 and D2L receptors couple to inward rectifier potassium channels in
mammalian cell lines. Mol Cell Neurosci
12: 390402.[Web of Science][Medline]
Lejeune F, Millan MJ (1995) Activation of dopamine D3
autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in
vivo. Eur J Pharmacol 275:
R79.[Web of Science][Medline]
L'Hirondel M, Cheramy A, Godeheu G, Artaud F, Saiardi A, Borrelli
E, Glowinski J (1998) Lack of autoreceptor-mediated inhibitory
control of dopamine release in striatal synaptosomes of D2 receptor-deficient
mice. Brain Res 792:
253262.[Web of Science][Medline]
Liss B, Neu A, Roeper J (1999) The weaver mouse
gain-of-function phenotype of dopaminergic midbrain neurons is determined by
coactivation of wvGirk2 and K-ATP channels. J Neurosci
19:
88398848.[Abstract/Free Full Text]
Murer G, Adelbrecht C, Lauritzen I, Lesage F, Lazdunski M, Agid Y,
Raisman-Vozari R (1997) An immunocytochemical study on the
distribution of two G-protein-gated inward rectifier potassium channels (GIRK2
and GIRK4) in the adult rat brain. Neuroscience
80: 345357.[Web of Science][Medline]
Slesinger PA, Stoffel M, Jan YN, Jan LY (1997)
Defective gammaaminobutyric acid type B receptor-activated inwardly rectifying
K+ currents in cerebellar granule cells isolated from weaver and Girk2 null
mutant mice. Proc Natl Acad Sci USA 94:
1221012217.[Abstract/Free Full Text]
Surmeier DJ, Yan Z, Song WJ (1998) Coordinated
expression of dopamine receptors in neostriatal medium spiny neurons.
Adv Pharmacol 42:
10201023.
Tepper JM, Sun BC, Martin LP, Creese I (1997)
Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons
analyzed by antisense knockdown in vivo. J Neurosci
17:
25192530.[Abstract/Free Full Text]
Uezono Y, Akihara M, Kaibara M, Kawano C, Shibuya I, Ueda Y,
Yanagihara N, Toyohira Y, Yamashita H, Taniyama K, Izumi F (1998)
Activation of inwardly rectifying K+ channels by GABA-B receptors expressed in
Xenopus oocytes. NeuroReport 9:
583587.[Web of Science][Medline]
Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, LeMeur M,
Piazza PV, Borrelli E (2000) Distinct functions of the two
isoforms of dopamine D2 receptors. Nature
408:
199203.[Medline]
Yan Z, Song WJ, Surmeier DJ (1997) D2 dopamine
receptor reduce N-type Ca 2+ currents in rat neostriatal
cholinergic interneurons through a membrane-delimited, protein kinase
C-insensitive pathway. J Neurophysiol
77:
10031015.[Abstract/Free Full Text]
Zapata A, Witkin JM, Shippenberg TS (2001) Selective
D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low
doses. Neuropharmacology 41:
351359.[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
M. Vandecasteele, J. Glowinski, J.-M. Deniau, and L. Venance
Chemical transmission between dopaminergic neuron pairs
PNAS,
March 25, 2008;
105(12):
4904 - 4909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Beckstead and J. T. Williams
Long-Term Depression of a Dopamine IPSC
J. Neurosci.,
February 21, 2007;
27(8):
2074 - 2080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Guatteo, C. P. Bengtson, G. Bernardi, and N. B. Mercuri
Voltage-Gated Calcium Channels Mediate Intracellular Calcium Increase in Weaver Dopaminergic Neurons During Stimulation of D2 and GABAB Receptors
J Neurophysiol,
December 1, 2004;
92(6):
3368 - 3374.
[Abstract]
[Full Text]
[PDF]
|
 |
|